NCT02513147View on ClinicalTrials.gov

HIV Reservoir Dynamics After Switching to Dolutegravir in Patients on a PI and 2 NRTI Based Regimen

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
HIV-1
Interventions
DRUG

Dolutegravir

DRUG

PI

(Fosamprenavir, atazanavir, lopinavir or darunavir) boosted with 100 mg of ritonavir, or atazanavir (400 mg / d) not boosted with ritonavir,if the 2 NRTIs are abacavir + Lamivudine

DRUG

2 NRTI

DRUG

2 NRTI

Trial Locations (1)

08035

Hospital Universitari Vall d'Hebron, Barcelona

All Listed Sponsors
collaborator

University Hospital, Ghent

OTHER

collaborator

IrsiCaixa

OTHER

lead

Hospital Universitari Vall d'Hebron Research Institute

OTHER

NCT02513147 - HIV Reservoir Dynamics After Switching to Dolutegravir in Patients on a PI and 2 NRTI Based Regimen | Biotech Hunter | Biotech Hunter